Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.

Q4 2025 earnings call recap: revenue, margins, Q1 2026 guidance, inventory burn-down and custom IC strategy—read key insights now.

Gov. Mike Dunleavy's proposed sales tax could clash with existing revenue measures in cities and boroughs across the state, lawmakers said during a House Finance Committee hearing on Thursday.

Maryland coaches say NIL has reached Olympic sports, but uneven funding and recruiting pressures are redefining how those ...

RXO, Inc. (NYSE:RXO) Q4 2025 Earnings Call Transcript February 6, 2026 RXO, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.04. Operator: Welcome to the RXO, ...

For decades, retirees chose where to live based on weather, family proximity, and lifestyle preferences. Taxes mattered, but ...

Tech's megacaps announced major increases in capex spend for 2026, and now investors are preparing for cash to dwindle.

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026 Adaptive Biotechnologies ...

The first supermodel stars in Burberry's Summer 2026 campaign ...

Adaptive Biotechnologies Corp (ADPT) reports impressive year-over-year growth, strategic integrations, and a robust cash position, while addressing potential challenges in the competitive landscape.

Anthropic on Thursday released its latest high-performing artificial intelligence model, escalating its challenge to OpenAI ...